toosendanin has been researched along with Breast Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baojin, H; Fangzhou, Y; Kai, W; Kaiyong, Y; Lin, M; Wu, Y; Yan, C; Yating, S | 1 |
1 other study(ies) available for toosendanin and Breast Cancer
| Article | Year |
|---|---|
Natural product toosendanin reverses the resistance of human breast cancer cells to adriamycin as a novel PI3K inhibitor.
Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line; Doxorubicin; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Female; Humans; Mice, Inbred BALB C; Molecular Structure; Neoplasms, Experimental; Phosphatidylinositol 3-Kinases; Phytotherapy | 2018 |